Tech Company Financing Transactions
Vtesse Funding Round
Alexandria Venture Investments, Bay City Capital and Lundbeckfond Ventures participated in a $17 million Series A capital raise for Vtesse. This venture round was announced on 7/26/2016.
Transaction Overview
Company Name
Announced On
7/26/2016
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series A
Investors
Proceeds Purpose
This additional capital enables Vtesse to broaden development and expand trial access to patients globally. The additional funding also allows Vtesse to invest in further product and technology improvements and to develop the commercial strategy to ensure product availability.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
910 Clopper Road 220S
Gaithersburg, MD 20878
USA
Gaithersburg, MD 20878
USA
Phone
Website
Email Address
Overview
The company has also established a Cooperative Research and Development Agreement (CRADA) with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Center for Advancing Translational Sciences (NCATS), each a component of the National Institutes of Health (NIH).
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/23/2016: TerraLUX venture capital transaction
Next: 7/26/2016: Sun Basket venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs